NFKB1 and Stroke: Triflusal, a treatment for stroke re-occurrence, targets four genes (PTGS1 (also known as Cox-1), NOS2, NFKB1, and PDE10A) that together have more functional variants in the African population than in any other population (DRPAFR = 37%; Fig. 4b).